about
Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancerReduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.Cloning, expression analysis and chromosomal localization of the human nuclear receptor gene GCNF.Long-Lasting Consequences of Testosterone ExposureMultiferroic coreshell magnetoelectric nanoparticles as NMR sensitive nanoprobes for cancer cell detection.Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activitiesIdentification of small-molecule agonists of human relaxin family receptor 1 (RXFP1) by using a homogenous cell-based cAMP assay.Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.Base excision repair of chemotherapeutically-induced alkylated DNA damage predominantly causes contractions of expanded GAA repeats associated with Friedreich's ataxia.Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290.Androgen receptor action in hormone-dependent and recurrent prostate cancer.Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase.INPP4B is an oncogenic regulator in human colon cancer.Androgen receptor coactivators and prostate cancer.INPP4B suppresses prostate cancer cell invasionAndrogens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.Erratum: Multiferroic coreshell magnetoelectric nanoparticles as NMR sensitive nanoprobes for cancer cell detectionA germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk.Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.Biodistribution and pharmacokinetics of aerosol and intravenously administered DNA-polyethyleneimine complexes: optimization of pulmonary delivery and retentionInositol polyphosphate 4-phosphatase type II regulation of androgen receptor activityDeletion of inositol polyphosphate 4-phosphatase type-II B affects spermatogenesis in mice
P50
Q28261539-05B1804F-2CA1-40C6-B6C4-A6B20319AB11Q30419961-85538569-C13F-4A45-BEE2-C47A38E2C88FQ32069085-42A2A4FB-5F51-4F5A-AD49-D1702BEF220DQ33585078-A3228349-92F3-4422-8CCC-CC27F1D7817BQ33686250-F08438A2-2097-49CE-AD77-D8B4EA7B421AQ34158474-8527D2E7-7F9E-4281-A8D6-7BB9F444A438Q34373594-DE09139E-6FA9-4C8F-AC22-8A5E6FBF0BDBQ34501476-A91449E9-16A8-4297-BCD6-141D11095F6DQ34771756-77A03CC2-9FA1-4A99-92E8-DC3029EADA68Q35137677-44733F50-D20F-4629-8D49-AC308EE839A9Q35960484-E682D684-2F6C-4D38-975E-8B51C23A8624Q36451090-4754C953-DFDE-4C22-82FE-A18761C7E6F9Q36971853-06508949-8F49-4154-AA9C-6BFA740DF965Q37005755-CC6077DB-4026-467C-9CD7-8C5656B9853CQ37170528-AE118D67-6C4D-40B7-B596-ABEC758D3C9EQ38953956-0CD8519F-6BD4-4E8B-A184-FDFC6203CD16Q40213081-D7BA68FE-C713-4B3E-9F9B-D05F4721A689Q40377759-0507A02C-40AC-417C-B884-9817D7D7FF2AQ42620593-3B710A10-9E37-496C-91AD-A6650EF6563BQ45173699-33E8682F-E76B-4544-B8AD-F9CBAD6871F3Q45309685-2D8FEE47-80D0-49A3-B0F7-567390BC8591Q46914162-41B97F57-61D1-42EA-BBE4-0C7F8D3A6090Q73782962-4ED54B6A-764E-4EEB-848C-CF053C114731Q91519231-581E7227-79E6-403A-8E7B-1CAB705F2A44Q94937808-96D11F36-D050-4348-9A2E-418460E6CAC9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Irina U. Agoulnik
@ast
Irina U. Agoulnik
@en
Irina U. Agoulnik
@es
Irina U. Agoulnik
@nl
Irina U. Agoulnik
@sl
type
label
Irina U. Agoulnik
@ast
Irina U. Agoulnik
@en
Irina U. Agoulnik
@es
Irina U. Agoulnik
@nl
Irina U. Agoulnik
@sl
prefLabel
Irina U. Agoulnik
@ast
Irina U. Agoulnik
@en
Irina U. Agoulnik
@es
Irina U. Agoulnik
@nl
Irina U. Agoulnik
@sl
P106
P1153
35577474300
P21
P31
P496
0000-0003-4889-0324